How the Trump administration's health cuts could kill thousands of test animals
Of the more than 900 animals located at a West Virginia-based National Institute for Occupational Safety and Health facility, a third were killed last week following layoffs there, according to a report from The New York Times. Now, scientists caution that this concerning outcome could happen again, as the National Institutes of Health caps indirect costs, including facilities and administration costs.
'If the animals can't be fed and cared for properly, then they're going to have to be sacrificed,' Dr. Paul Locke, an environmental health scientist, attorney and professor at the Johns Hopkins Bloomberg School of Public Health, told The Independent. 'And that, to me, is just a parade of horribles.'
'Some people may tell you that this massive culling is OK because what it means is that animal research is going to end. But, that is simply not true. The animal research will not end. It will simply go somewhere else,' he said.
Where it would go remains to be seen, and the future of animal testing is murky. Locke said his guess is that it could continue to be done in the U.S. in a way where it escapes protection or in places where there are a lot less protections for the animals.
A spokesperson for the Department of Health and Human Services did not address the situation in West Virginia, but told The Independent that it was committed to maintaining compliance with all federal animal welfare standards throughout this transition period and that it remains focused on ensuring public health, research and regulatory obligations continue to be met responsibly and in accordance with applicable law.
The Trump administration's Food and Drug Administration has recently moved to 'phase out' animal testing for certain drugs.'
Animal groups have commended the action — but also say the nation is not moving fast enough. They dispute the claim that lab animals are such a critical part of U.S. health research.
'I think we need to give up that ghost. Especially because of all the non-animal methods that are available and are emerging,' Dr. Katherine Roe, a neuroscientist and PETA's chief of science advancement and outreach, said. PETA is the nation's largest animal rights group.
'It's not a gold standard,' she said.
Roe pointed out that there are limitations to these practices, including that many people who utilize animal studies tend to lean into how they're similar to humans versus how they are different.
'The failure rate for treatments developed in animals for cancer, for sepsis, for Alzheimer's disease go on and fail when they're tried in human patients because of species differences,' she noted, adding that the lab environment alters the physiology of the animals.
'The idea that we should keep trying this failed paradigm ... is ridiculous,' said Roe.
'I think we are bumping up against the limits of what animals can tell us,' noted Locke, 'and, there are many reasons for that. but the simple biological reason is that human biology is different than animal biology.'
He believes that there should be a transition away from animal testing while alternatives are developed.
'FDA and EPA have been pressed for decades to champion innovative methods that use human cells, 3D printing, robotics, computer models and other technologies to assess the safety and efficacy of a host of chemicals, products, devices and drugs without the suffering and death of literally hundreds of thousands of animals,' Sara Amundson, president of Humane World Action Fund, said in a statement.
PETA estimates that are still 100 million animals in U.S. laboratories, but says that count is likely an underestimate. It's a tally that doesn't include animals not protected under the Animal Welfare Act. So, it doesn't include mice, rats, fish and birds that are bred for research purposes.
Some of the millions of animals could be moved, but many may have already been exposed to pathogens. It is unclear where all of these animals could go, if not to sanctuaries. Many others are rescued from facilities.
The industry has a duty to figure out the animal's future, Animal Legal Defense Fund Senior Staff Attorney Caitlin Foley said in a statement shared with The Independent.
'[The Animal Legal Defense Fund] urges Congress to pass similar legislation to the CHIMP Act (Chimpanzee Health Improvement, Maintenance, and Protection Act) to require the adoption or rehoming of all animals forced into animal research,' she wrote. The CHIMP Act is a federal law that mandates the creation of a system of sanctuaries for chimpanzees no longer needed in research.
But, without these or similar avenues, Roe says the animals' option is death. It may be their best option before experimentation, Justin Goodman, a senior vice president at the White Coat Waste Project, told Rawstory.
'The reality is that these animals were always at risk for euthanasia. In fact, the overwhelming majority of animals in laboratories are killed at the end of experimentation,' Roe added. 'That's the truth.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

USA Today
an hour ago
- USA Today
Nevada Rep. Mark Amodei explains yes vote on Trump's budget bill, Medicaid changes
Only one member of Congress from Nevada voted in favor of President Donald Trump's budget bill and its Medicaid cuts: Rep. Mark Amodei. Trump plans to sign the bill into law at 2 p.m. Pacific time July 4. After the U.S. House approved the bill July 3, Amodei released a lengthy statement explaining his decision to support what he called historic legislation to address the Biden administration's mismanagement. 'As with any major reform bill, the One Big Beautiful Bill is a balancing act,' he said, referring to its legislative name inspired by Trump's language. 'I have long believed that we can't let perfect be the enemy of good, and our work won't stop here in getting Nevadans the relief they need.' Amodei disputed claims the bill is only a handout to the wealthy and characterized it as helping everyday working families. Amodei's bill highlights Among Amodei's highlights for the bill are that: 'Claims that this bill harms veterans are nothing more than political scare tactics and gaslighting,' he said. 'The legislative text contains no provisions explicitly targeting veterans, and veterans receiving VA benefits will continue to do so without interruption.' Amodei on Medicaid changes Amodei, a Republican who represents the top half of Nevada, noted that discussions around the bill have focused on Medicaid. Sen. Catherine Cortez Masto, a Nevada Democrat, hammered the bill the day before its passage, calling it 'mean and cruel.' She noted that estimates show 114,500 Nevadans are expected to lose health care coverage. Northern Nevada HOPES, which serves low-income patients, said the bill will force a 30% reduction in the number of people it can said Medicaid has exploded in size since it started in 1965. 'Since the enactment of the Affordable Care Act,' his news release said, 'Medicaid has shifted away from its original mission of serving the traditional low-income population, evolving instead into a de facto state-run universal healthcare system.' In fiscal year 2023, he said, Nevada spent 30% of its budget on Medicaid, $5.6 billion. 'The One Big Beautiful Bill addresses and reins in these excessive Medicaid costs by establishing commonsense work requirements for able-bodied adults without young dependents,' Amodei said. 'In addition, the bill strengthens program integrity measures that protect Medicaid resources for the most vulnerable such as children, pregnant women, people with disabilities and low-income families.' More: 'Cruel' Medicaid cuts in Trump budget bill cuts to hurt Nevada, Sen. Cortez Masto says Funding for rural hospitals There's a balancing act, he said, between reining in out-of-control Medicaid spending and protecting Nevada's hospitals and health clinics. To offset decreases in Medicaid funding for hospitals, Republicans added the Rural Hospital Stabilization Fund to the bill. This, Amodei said, 'will provide $50 billion in relief from 2028 through 2032 for rural hospitals.' Pat Kelly of the Nevada Hospital Association said it's unclear how much help it'll bring. At Cortez Masto's news conference, Kelly said that the federal budget bill's changes to the provider tax rate will decrease hospital funds. 'The total effect by state fiscal year 2029 on Nevada hospitals,' he said, 'will be a loss of $618 million in payments.' Kelly noted the $50 billion fund mentioned by Amodei in the federal budget bill. 'But that provision,' he said, 'is not just for rural hospitals. It's for all providers in rural areas so we're not sure how much is going to be available for hospitals. If there's a group that truly needs our support, it's our rural hospitals.' Amodei said the bill gives the state two years to prepare for changes to the Medicaid provider tax supporting hospitals. 'A perfect solution to healthcare costs has eluded us again,' he said, 'but it will be interesting to see what the Centers for Medicare and Medicaid Services do with implementation of these new Medicaid policies and future rules and regulations. 'I look forward to continuing to work with CMS, the Nevada Health Authority, and our local stakeholders on these issues.' Mark Robison is the state politics reporter for the Reno Gazette Journal, with occasional forays into other topics. Email comments to mrobison@ or comment on Mark's Greater Reno Facebook page.


San Francisco Chronicle
2 hours ago
- San Francisco Chronicle
EPA puts on leave 139 employees who spoke out against policies under Trump
The Environmental Protection Agency on Thursday put on administrative leave 139 employees who signed a 'declaration of dissent' with its policies, accusing them of 'unlawfully undermining' the Trump administration's agenda. In a letter made public Monday, the employees wrote that the agency is no longer living up to its mission to protect human health and the environment. The letter represented rare public criticism from agency employees who knew they could face blowback for speaking out against a weakening of funding and federal support for climate, environmental and health science. In a statement Thursday, the EPA said it has a 'zero-tolerance policy for career bureaucrats unlawfully undermining, sabotaging and undercutting' the Trump administration's agenda. Employees were notified that they had been placed in a 'temporary, non-duty, paid status' for the next two weeks, pending an 'administrative investigation,' according to a copy of the email obtained by The Associated Press. 'It is important that you understand that this is not a disciplinary action,' the email read. More than 170 EPA employees put their names to the document, with about 100 more signing anonymously out of fear of retaliation, according to Jeremy Berg, a former editor-in-chief of Science magazine who is not an EPA employee but was among non-EPA scientists or academics to also sign. Scientists at the National Institutes of Health made a similar move in June, when nearly 100 employees signed a declaration that assailed Trump administration 'policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe.' An additional 250 of their colleagues endorsed the declaration without using their names. But no one at NIH has been placed on administrative leave for signing the declaration and there has been no known retribution against them, Jenna Norton, a lead organizer of the statement, told AP on Thursday. Norton oversees health disparity research at the agency's National Institute of Diabetes and Digestive and Kidney Diseases. NIH Director Jay Bhattacharya, in his confirmation hearings, had pledged openness to views that might conflict with his own, saying dissent is the 'essence of science.' Under Administrator Lee Zeldin, EPA has cut funding for environmental improvements in minority communities, vowed to roll back federal regulations that lower air pollution in national parks and tribal reservations, wants to undo a ban on a type of asbestos and proposed repealing rules that limit planet-warming greenhouse gas emissions from power plants fueled by coal and natural gas. Zeldin began reorganizing the EPA's research and development office as part of his push to slash its budget and gut its study of climate change and environmental justice. And he's seeking to roll back pollution rules that an AP examination found were estimated to save 30,000 lives and $275 billion every year. The EPA responded to the employees' letter earlier this week by saying policy decisions 'are a result of a process where Administrator Zeldin is briefed on the latest research and science by EPA's career professionals, and the vast majority who are consummate professionals who take pride in the work this agency does day in and day out.' ___
Yahoo
3 hours ago
- Yahoo
Hims & Hers Enhances Healthcare Through AI-Driven Personalization
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, is actively leveraging artificial intelligence (AI) to revolutionize the delivery of healthcare, aiming to make it more personalized, scalable, and accessible. The company has strategically invested in expanding its AI capabilities, marked by the appointment of Mo Elshenawy — former president and chief technology officer (CTO) at Cruise and an AI expert — as its CTO in May. Elshenawy's expertise is expected to drive the development of an AI-powered healthcare platform that integrates diagnosis, treatment and delivery into a seamless and individualized experience. He emphasized that Hims & Hers is uniquely positioned to lead a healthcare transformation by using AI and data to deliver care that is smarter, more adaptive and deeply attuned to each patient's needs. To support this transformation, Hims & Hers recently raised $870 million in convertible notes in May, a portion of which is earmarked to advance AI tools, expand the company's data pipeline and enhance personalized treatments. This funding reflects HIMS' intention to modernize healthcare infrastructure using AI, not only to improve diagnostic accuracy but also to create a more intuitive and efficient patient journey. Their existing initiatives, such as the intelligent MedMatch routing system and efforts to deepen technological personalization, illustrate a clear roadmap for integrating AI into core operational processes. These developments position Hims & Hers at the forefront of AI-enabled healthcare delivery. Teladoc Health, Inc. TDOC is harnessing AI to strengthen its virtual care ecosystem, enhance diagnostics and personalize care delivery. Teladoc Health integrates AI across clinical workflows, using it for intelligent triage, patient engagement and predictive analytics to improve outcomes and operational efficiency. TDOC continues to scale its AI capabilities to support complex chronic condition management and behavioral health services. Through these innovations, Teladoc Health positions itself as a leading digital health provider, leveraging AI to expand access and elevate patient experiences. Tempus AI, Inc. TEM is deeply embedding AI across its precision medicine operations, using its proprietary AI platform, Lens, to analyze multimodal healthcare data. Tempus AI drives innovation in oncology and neurogenomics, notably through a collaboration with Northwestern University's Abrams Research Center to apply AI in Alzheimer's research. TEM also integrates AI into its diagnostics and data services, enabling real-time clinical decision support. Through this approach, Tempus AI is transforming healthcare by advancing targeted therapies, optimizing clinical workflows and scaling personalized treatment models. Shares of Hims & Hers have gained 95.7% year to date compared with the industry's growth of 19.7%. Image Source: Zacks Investment Research HIMS' forward 12-month P/S of 4.1X is lower than the industry's average of 5.8X, but is higher than its three-year median of 2.3X. It carries a Value Score of C. Image Source: Zacks Investment Research The Zacks Consensus Estimate for HIMS' 2025 earnings per share suggests a 174.1% improvement from 2024. Image Source: Zacks Investment Research Hims & Hers stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report Tempus AI, Inc. (TEM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data